Clinical Trial to Evaluate CD19 CAR T (CT032) in Patients With Relapsed and/or Refractory Non-Hodgkin's B Cell Lymphoma

Clinical trial NCT03994913 · COMPLETED

Trial details

NCT number: NCT03994913
Sponsor: CARsgen Therapeutics Co., Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Refractory B-Cell Non-Hodgkin Lymphoma Relapsed B-cell Non-Hodgkin Lymphoma

Start date: 2019-08-14
Primary completion: 2021-01-20
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.